Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib, Dose-finding and Pharmacodynamic Study of NVX-508 in Sickle Cell Disease Patients

NCT03013426 is registered in ClinicalTrials.gov with Amma Owusu-Ansah, MD as lead sponsor.

NCT NCT03013426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib, Dose-finding and Pharmacodynamic Study of NVX-508 in Sickle Cell Disease Patients
Lead sponsor
Amma Owusu-Ansah, MD
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2018
Completion date
December 31, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease